Study reveals viable alternative for patients with refractory disease
Cleveland Clinic to lead four-center, 400-patient randomized trial
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy